Therapy of non alcoholic fatty liver disease

Phase 3

Recruiting

• Conditions: on alcoholic fatty liver disease.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20211014052767N1
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

Grade 2 and 3 non-alcoholic fatty liver disease based on the latest ultrasound findings

Exclusion Criteria

History of long term alcohol consumption
History chronic and acute viral and autoimmune hepatitis, type 1 diabetes, cholestatic diseases including cholecystitis, kidney, thyroid disease, various malignancies, severe infectious diseases, cardiovascular disease and immune deficiency
History of pioglitazone, metformin, NSAIDs, fibrates, statins and warfarin
Pregnancy and lactation
History of corticosteroids and steroid compounds in the last three months
Controlled diet or strenuous exercise

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver sonographic findings. Timepoint: At the beginning of the study and 3 months after the start of the drug intervention. Method of measurement: Based on the classification of fatty liver.;Liver enzymes. Timepoint: At the beginning of the study and 3 months after the start of the drug intervention. Method of measurement: Laboratory data.